Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,992.40
(
0.47%
)
Dow Jones
49,447.43
(
0.00%
)
Brent Oil
91.52
(
0.93%
)
Bitcoin
76,625.99
(
0.97%
)
News Focus
News Focus
Post# of 517463
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27742
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: XenaLives post# 179042

Monday, 01/21/2019 6:01:10 AM

Monday, January 21, 2019 6:01:10 AM

Post# of 517463
One thing it does point to is that taking and analysing CSF is important.

Good to see that the Anavex P2b/3 study checks for markers in CSF. We can hope that in doing so these various studies are known to those involved with running the trial.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News